Related Experiment Videos
Orbitotemporal neurofibromatosis: classification and treatment
I T Jackson1, A Carbonnel, Z Potparic
1Institute for Craniofacial Surgery, Providence Hospital, Southfield, Mich.
Plastic and Reconstructive Surgery
|July 1, 1993
Summary
Treatment for localized orbitotemporal neurofibromatosis varies by orbital involvement and eye function. This study categorizes patients into three groups based on soft-tissue and bony involvement, guiding tailored therapeutic strategies.
Area of Science:
- Ophthalmology
- Neurosurgery
- Oncology
Background:
- Localized orbitotemporal neurofibromatosis presents complex challenges in management.
- Treatment decisions are dictated by the extent of orbital disease and visual status.
Purpose of the Study:
- To propose a treatment stratification for localized orbitotemporal neurofibromatosis.
- To correlate treatment approaches with disease characteristics and patient outcomes.
Main Methods:
- Classification of 24 patients into three distinct groups based on orbital soft-tissue and bony involvement, and visual function.
- Analysis of treatment strategies and recurrence-free follow-up data.
Main Results:
- Group 1: Orbital soft-tissue involvement with a seeing eye.
- Group 2: Orbital soft-tissue and significant bony involvement with a seeing eye.
- Group 3: Orbital soft-tissue and significant bony involvement with a blind or absent eye.
Conclusions:
- A structured approach to treatment based on disease severity and visual status is crucial for localized orbitotemporal neurofibromatosis.
- Management strategies should be individualized to optimize outcomes and minimize recurrence.